MONROVIA, CA, July 21, 2012 (Press-News.org) Dave Shelton, Senior Director at Pfizer Global Research & Development will give a featured presentation on "Update on Clinical Development of NGF Inhibitors for Pain" at the Pain Research and Therapeutics Conference taking place on Sept 13-14, 2012 in San Francisco, CA.
Chronic Pain has been clinically diagnosed in 40 million people in the United States alone. Over the counter analgesics for chronic pain include non steroidal anti-inflammatories (NSAIDs) and opioids. The analgesic potency of these drugs is very limited and the side effects can include gastrointestinal bleeding and ulceration and renal toxicity, drowsiness/sedation, nausea and vomiting, constipation and the potential for abuse and dependence.
Pfizer has been working on an exciting, newly developed modulator of pain that does not fall into the category of NSAIDs or opioids and their side effects, called Nerve Growth Factor (NGF) Inhibitors. NGF is a cytokine that binds to receptors on peripheral sensory neurons and sensitizes these neurons and lowers pain threshold. In his presentation, Dr. Shelton will provide an update on the clinical development of NGF Inhibitors for pain.
GTC's Pain Research and Therapeutics will discuss the latest breakthroughs, new drug targets, therapeutic approaches, preclinical and clinical development, animal models, beyond traditional opioids, overcoming challenges in pain therapeutics, and much more. The conference is also a part of the 2nd CNS Diseases World Summit. The Summit brings together the leading experts across the industry and academia to discuss the latest research and developments in the CNS field. The summit has four parallel tracks that focus on neurodegenerative conditions, neuropsychiatric disorders, pain research and therapeutics and CNS partnering and deal-making.
Join colleagues at this exciting Pain Therapeutics conference and CNS summit, and hear from and meet with key representatives in the field including Charles B. Nemeroff at University of Miami, Stephen Brannan - VP at Takeda, Husseini Manji - Global Head of Neuroscience Therapeutic at Janssen, Barry Brand - Chief Executive Officer at CeNeRx, David Shelton at Pfizer, George Garibaldi - Global Head of CNS Clinical Development at F. Hoffmann-La Roche, Tony W. Ho - Vice President at AstraZeneca, Michael C. Venuti - CSO at NeuroTherapeutics, and many more!
For more information, please visit http://www.gtcbio.com
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
Dave Shelton at Pfizer to speak about NGF Inhibitors for Pain on Sept 13-14, 2012 San Francisco, CA
Dave Shelton, Senior Director at Pfizer Global Research & Development will give a featured presentation about NGF Inhibitors for Pain at the Pain Research and Therapeutics Conference (Sept 13-14, 2012 in San Francisco, CA)
2012-07-21
ELSE PRESS RELEASES FROM THIS DATE:
EcoSafe Washer Filling the OCD Protection Void, Says ALSCO
2012-07-21
The report, which was published in March of this year, drew from 3 surveys carried out over the past two years - 2 by the National Hazard Exposure Worker Surveillance (NHEWS) (March 2011 and 2012); and 1 review of patch testing data gathered over 18 years at a Victorian referral clinic specialising in OCD (March 2012).
The report stated that: âEUR˜smaller workplaces were least likely to provide the surveyed control measures and most likely to provided none of the control measures to exposed workersâEUR .
But, Alsco has pointed out that the EcoSafe Washer is as ideally ...
FleetwoodGoldcoWyard Revitalizes Process Systems
2012-07-21
FleetwoodGoldcoWyard's specialized technology group, Fleetwood Process Systems, is reintroducing In-Line Batch Creation, Quasi-Blending Systems and the P-SMART Kit. By combining experience and industry-leading technologies with the CBI Fleetwood Volumix and the historic AMBEC product lines of FullMix and Quasi-Blend, systems can be molded together to create a unique and custom solution while maintaining the integrity of the tried and tested blending concepts.
Quasi-Blend Systems and other in-line batching operations provide clear opportunities for life-cycle savings. ...
Dorner Mfg. Corp. Joins Incline Equity Partners; Rich Ryan Named CEO
2012-07-21
Dorner Mfg. Corp. announced today its partnership with Incline Equity Partners of Pittsburgh, PA. Located in Hartland, Wis., Dorner is a leading designer, manufacturer and supplier of unit handling conveyor systems used to address automation needs in industrial, packaging, food, medical and pharmaceutical markets. Founded in 1969 by members of the Dorner family, Dorner is a leader in the high performance conveying equipment sector, having developed a robust product line from low profile industrial belt conveyors to food grade stainless steel conveyors used in sanitary environments.
"We ...
New All Natural Flea & Tick Repellent Spray For Dogs Grabs Attention Of Dog Lovers And Gives Back To Dogs in Need
2012-07-21
A Balanced K9, a company catering to the all natural needs of dogs, recently announced the launch of their new all natural canine flea and tick repellent, NatuRepel, offering a safe choice for people and canines to enjoy the great outdoors.
Formulated with only premium essential oils including lemongrass and cedar wood, NatuRepel is not only healthy for dogs, but also healthy for the environment.
"Our goal is to make the world a better place for everyone, dogs and people alike," states Paula Prickett, owner of A Balanced K9. "We have even taken every ...
Clothing line to be launched for Wisconsinites
2012-07-21
Clothing line to be launched for Wisconsinites. We are proud to announce the soft launch of the WI Wear Clothing website. We will initially offer a limited number of products to gauge and make improvements, before launching the entire web store. ****
Milwaukee based company offering high-quality Wisconsin themed apparel. The niche "Wisconsin" products will be sold under the "WI Wear Clothing line" (TM), with their own unique logo.
The "WI Wear Clothing line" will offer various options for; men, women, youth as well as toddlers. WI Wear ...
NJ Advertising Agency Produces Branded Marketing Materials For HSBC Insurance Product Launches
2012-07-21
CRK Advertising, Inc. has produced marketing materials for the launch of two new HSBC Insurance products, Optional Payment Protection (OPP) and Optional Income Protection (OIP).
CRK Advertising, Inc. developed the materials to display in HSBC Bank branches in the United States and Canada. The Canadian pieces were produced in French to accommodate the surrounding target market. The goal of the marketing materials produced was to appeal to pre-existing HSBC Bank customers as well as potential, untapped markets of customers.
"Adhering to the corporate guidelines ...
Announcing The Boy Game Transmedia Project: The Culture of Hyper-masculinity Engendering Bullying
2012-07-21
THE BOY GAME is a transmedia project (video and interactive website) that explores bullying not from the vantage point of the roles boys play, but the cultural landscape in which these roles flourish. Much focus is on getting schools to protect targets, which is critical, but the truth is boys can't be policed 24/7, and all boys, even bullies (who have most often been targeted themselves) suffer under hyper-masculine norms of toughness. Both the video and website are based on off-the-record interviews with boys nationwide and follow the stories of three boys: a bully, a ...
ACT Today! to Salute Actor Joe Mantegna and CBS TV Executive Steve Mauldin at 7th Annual Denim & Diamonds for Autism Fundraiser
2012-07-21
ACT Today! (Autism Care and Treatment Today!), a national non-profit organization whose mission is to provide access to care and treatment to children with autism, announces it will honor "Criminal Minds" star Joe Mantegna and KCBS 2 and KCAL 9's President and General Manager Steve Mauldin at its 7th Annual Denim & Diamonds for Autism fundraiser on Saturday, November 3, 2012 at the Calamigos Ranch in Malibu, California. Over 500 guests are expected to attend the red carpet fundraiser, including corporate leaders, celebrities, dignitaries and other autism supporters.
 

"Honoring ...
New London Online Dating Agency Service from LondonCityDate.com
2012-07-21
LondonCityDate.com is a new service that currently costs nothing to join, a new online dating community just for London. When members join, they can add a profile and photo to create a London dating agency page. The service enabled users to send 'winks' to contact other London guys and gals.
Using the services geographical search users are able to find others throughout the whole of the county also. Members can use more advanced search options to find more local members by their interests, age, post code, whether they have children, even their hair colour.
Richard ...
Social Media Marketing firm changing the landscape of social media marketing Tampa, Florida based Zidan Marketing & Media Inc.
2012-07-21
Zidan Marketing & Media Inc. is setting a new precedent for the fast paced social media realm. Social media is the world's biggest craze. Sites such as Facebook, MySpace, LinkedIn, Twitter, and YouTube allow people to connect immediately and directly.
Many businesses have seen this as an opportunity to directly reach consumers, allowing them to promote their products and services on a real time basis. The biggest benefit is the cost efficiency of social media marketing and its massive reach of audience, as well as the personal interaction it allows businesses to ...
LAST 30 PRESS RELEASES:
University of Cincinnati experts present research at annual hematology event
ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors
Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
Continuous and fixed-duration treatments result in similar outcomes for CLL
Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia
Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease
Roughly one-third of families with children being treated for leukemia struggle to pay living expenses
Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy
IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection
Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients
Emergency departments fall short on delivering timely treatment for sickle cell pain
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia
Early results suggest exa-cel gene therapy works well in children
NTIDE: Disability employment holds steady after data hiatus
Social lives of viruses affect antiviral resistance
Dose of psilocybin, dash of rabies point to treatment for depression
Helping health care providers navigate social, political, and legal barriers to patient care
Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments
Using smartphones to improve disaster search and rescue
Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing
Ultrafast material captures toxic PFAS at record speed and capacity
Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli
UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections
OYE Therapeutics closes $5M convertible note round, advancing toward clinical development
Membrane ‘neighborhood’ helps transporter protein regulate cell signaling
Naval aviator turned NPS doctoral student earns national recognition for applied quantum research
[Press-News.org] Dave Shelton at Pfizer to speak about NGF Inhibitors for Pain on Sept 13-14, 2012 San Francisco, CADave Shelton, Senior Director at Pfizer Global Research & Development will give a featured presentation about NGF Inhibitors for Pain at the Pain Research and Therapeutics Conference (Sept 13-14, 2012 in San Francisco, CA)